Trials / Completed
CompletedNCT05347849
Single Ascending Dose Study With BPL-003 in Healthy Subjects
A Two-part Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal BPL-003 (5-Methoxy-N,N-dimethyltryptamine Benzoate) in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Beckley Psytech Limited · Industry
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study will evaluate safety, tolerability and PK profile of BPL-003 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BPL-003 | A single dose of BPL-003 will be administered intranasally |
| OTHER | Placebo | A single dose of placebo will be administered intranasally |
Timeline
- Start date
- 2022-02-14
- Primary completion
- 2024-01-19
- Completion
- 2024-01-19
- First posted
- 2022-04-26
- Last updated
- 2024-03-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05347849. Inclusion in this directory is not an endorsement.